Depletion and Recovery of CD4 Populations
Patient No. . | Age . | Stage . | Prior Treatment . | CD4+ Count . | CD4+ CD45RA+ Count . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Before Therapy . | Nadir . | After 6 Mo . | After 12 Mo . | Before Therapy . | Nadir . | After 6 Mo . | After 12 Mo . |
9445 | 33 | II | 0 | 649 | 259 | 165 | * | 227 | 37 | 20 | * |
9446 | 33 | II | 0 | 583 | 240 | 292 | 281 | 157 | 6 | 18 | 44 |
9439 | 39 | II | 0 | 671 | 324 | 110 | 217 | 310 | 97 | 55 | 66 |
9305 | 39 | IV | 0 | 851 | 407 | 383 | 212 | ||||
9455 | 39 | IIIB | 0 | 750 | 331 | 346† | 187 | 22 | 36† | ||
9430 | 40 | IV | CA | 281 | 199 | 456 | * | 76 | 1 | 10 | * |
9448 | 40 | II | 0 | 1,616 | 237 | 346 | 748 | 693 | 9 | 27 | 187 |
9327 | 41 | IV | CMF | 336 | 187 | 536 | * | 49 | 2 | 81 | * |
9335 | 41 | IIB | 0 | 1,254 | 442 | 553 | 345 | 27 | 99 | ||
9452 | 43 | IIIB | 0 | 1,044 | 127 | 355 | * | 206 | 6 | 98 | * |
9407 | 46 | IV | 0 | 596 | 222 | 226 | 103 | 7 | 27 | ||
9338 | 46 | IV | 0 | 962 | 474 | 417 | 530 | 191 | 10 | 30 | |
9411 | 47 | III | 0 | 599 | 167 | 556 | 379 | 106 | 18 | 111 | 110 |
9349 | 48 | II | 0 | 755 | 271 | 531 | 243 | 40 | 7 | 26 | 17 |
9449 | 48 | III | 0 | 970 | 284 | 391 | 219 | 441 | 16 | 51 | 51 |
9441 | 49 | II | 0 | 958 | 205 | 256 | 437 | 28 | 43 | ||
9447 | 49 | IV | CMF | 538 | 421 | 517 | 379 | 83 | 28 | 47 | 18 |
9344 | 51 | III | 0 | 767 | 202 | 636 | 213 | 10 | 99 | ||
9306 | 51 | III | 0 | 1,034 | 270 | 294 | 421 | 225 | 4 | 31 | 79 |
9307 | 53 | III | 0 | 1,105 | 288 | 770 | * | 262 | 41 | 131 | * |
9436 | 54 | IIB | 0 | 1,180 | 68 | 168 | 186‡ | 229 | 5 | 13 | 20‡ |
9422 | 55 | II | 0 | 939 | 380 | 505 | 384‡ | 95 | 25 | 49 | 30‡ |
9322 | 60 | IV | TAM | 587 | 192 | 412 | * | 193 | 6 | 48 | * |
9409 | 68 | IV | CMF | 920 | 321 | 757 | 529‡ | 112 | 7 | 29 | 77 |
9424 | 69 | IIIB | 0 | 796 | 244 | 387 | 372 | 184 | 95 | 108 |
Patient No. . | Age . | Stage . | Prior Treatment . | CD4+ Count . | CD4+ CD45RA+ Count . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | . | Before Therapy . | Nadir . | After 6 Mo . | After 12 Mo . | Before Therapy . | Nadir . | After 6 Mo . | After 12 Mo . |
9445 | 33 | II | 0 | 649 | 259 | 165 | * | 227 | 37 | 20 | * |
9446 | 33 | II | 0 | 583 | 240 | 292 | 281 | 157 | 6 | 18 | 44 |
9439 | 39 | II | 0 | 671 | 324 | 110 | 217 | 310 | 97 | 55 | 66 |
9305 | 39 | IV | 0 | 851 | 407 | 383 | 212 | ||||
9455 | 39 | IIIB | 0 | 750 | 331 | 346† | 187 | 22 | 36† | ||
9430 | 40 | IV | CA | 281 | 199 | 456 | * | 76 | 1 | 10 | * |
9448 | 40 | II | 0 | 1,616 | 237 | 346 | 748 | 693 | 9 | 27 | 187 |
9327 | 41 | IV | CMF | 336 | 187 | 536 | * | 49 | 2 | 81 | * |
9335 | 41 | IIB | 0 | 1,254 | 442 | 553 | 345 | 27 | 99 | ||
9452 | 43 | IIIB | 0 | 1,044 | 127 | 355 | * | 206 | 6 | 98 | * |
9407 | 46 | IV | 0 | 596 | 222 | 226 | 103 | 7 | 27 | ||
9338 | 46 | IV | 0 | 962 | 474 | 417 | 530 | 191 | 10 | 30 | |
9411 | 47 | III | 0 | 599 | 167 | 556 | 379 | 106 | 18 | 111 | 110 |
9349 | 48 | II | 0 | 755 | 271 | 531 | 243 | 40 | 7 | 26 | 17 |
9449 | 48 | III | 0 | 970 | 284 | 391 | 219 | 441 | 16 | 51 | 51 |
9441 | 49 | II | 0 | 958 | 205 | 256 | 437 | 28 | 43 | ||
9447 | 49 | IV | CMF | 538 | 421 | 517 | 379 | 83 | 28 | 47 | 18 |
9344 | 51 | III | 0 | 767 | 202 | 636 | 213 | 10 | 99 | ||
9306 | 51 | III | 0 | 1,034 | 270 | 294 | 421 | 225 | 4 | 31 | 79 |
9307 | 53 | III | 0 | 1,105 | 288 | 770 | * | 262 | 41 | 131 | * |
9436 | 54 | IIB | 0 | 1,180 | 68 | 168 | 186‡ | 229 | 5 | 13 | 20‡ |
9422 | 55 | II | 0 | 939 | 380 | 505 | 384‡ | 95 | 25 | 49 | 30‡ |
9322 | 60 | IV | TAM | 587 | 192 | 412 | * | 193 | 6 | 48 | * |
9409 | 68 | IV | CMF | 920 | 321 | 757 | 529‡ | 112 | 7 | 29 | 77 |
9424 | 69 | IIIB | 0 | 796 | 244 | 387 | 372 | 184 | 95 | 108 |